1. Powell FC. Rosacea. New England Journal of Medicine. 2005 Feb 24;352(8):793-803.
2. Rivero AL, Whitfeld M. An update on the treatment of rosacea. Australian prescriber. 2018 Feb;41(1):20.
3. Korting HC, Schöllmann C. Current topical and systemic approaches to treatment of rosacea. Journal of the European Academy of Dermatology and Venereology. 2009 Aug;23(8):876-82.
4. Del Rosso JQ, Webster GF, Rosen T, Thiboutot D, Leyden JJ, Gallo R, Walker C, Zhanel G, Eichenfield L. Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use. The Journal of clinical and aesthetic dermatology. 2016 Apr;9(4):18.
5. Schaller M, Schöfer H, Homey B, Gieler U, Lehmann P, Luger TA, Ruzicka T, Steinhoff M. State of the art: Systemic rosacea management. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2016 Dec;14:29-37.
6. Van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database of Systematic Reviews. 2015(4).
7. Parodi A, Drago F, Paolino S, Cozzani E, Gallo R. Treatment of rosacea. In Annales de dermatologie et de venereologie 2011 Nov 1 (Vol. 138, pp. S211-S214). Elsevier Masson.
8. Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. Journal of the American Academy of Dermatology. 2007 May 1;56(5):791-802.
9. Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D. Rosacea treatment update: recommendations from the global ROS acea CO nsensus (ROSCO) panel. British Journal of Dermatology. 2017 Feb;176(2):465-71.
10. Wladis EJ, Adam AP. Treatment of ocular rosacea. Survey of ophthalmology. 2018 May 1;63(3):340-6.
11. Webster G, Schaller M. Ocular rosacea: a dermatologic perspective. Journal of the American Academy of Dermatology. 2013 Dec 1;69(6):S42-3.
12. Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis. 2013 Dec 1;92(6):277-84.
13. Fernandez-Obregon A. Oral use of azithromycin for the treatment of acne rosacea. Archives of dermatology. 2004 Apr 1;140(4):489-90.
14. Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis. 2013 Dec 1;92(6):277-84.
15. Sanchez J, Somolinos AL, Almodóvar PI, Webster G, Bradshaw M, Powala C. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. Journal of the American Academy of Dermatology. 2005 Nov 1;53(5):791-7.
16. Fowler JJ. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. Journal of drugs in dermatology: JDD. 2007 Jun;6(6):641-5.